1-3 of 3
William J Archibald
Close
Sort by
Journal Articles

The Role of Splenectomy in Management of Splenic B-Cell Lymphomas

William J Archibald, Andrea M Baran, Annalynn M Williams, Chauncey Syposs, Rabih M Salloum, Andrew G Evans, Clive S. Zent
Journal: Blood
Blood (2022) 140 (Supplement 1): 11964–11965.
https://doi.org/10.1182/blood-2022-165496
Published: 2022
Journal Articles

Real-World First-Line Treatment and Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Bruton Tyrosine Kinase Inhibitor (BTKi) or B-Cell Lymphoma 2 (BCL2) Therapy

William J Archibald, Anna Barcellos, Jacob Ambrose, Andrew J. Belli, Laura Fernandes, Eric Hansen, Ching-Kun Wang, Paul M. Barr
Journal: Blood
Blood (2022) 140 (Supplement 1): 4142–4143.
https://doi.org/10.1182/blood-2022-170596
Published: 2022
Journal Articles

The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell Lymphocytosis

William J Archibald, MDCPA, Timothy G. Call, MD, Sara J. Achenbach, Kari G Rabe, Curtis A. Hanson, MD, Wei Ding, MD PhD, Amber Koehler, PA-C, MS, Eli Muchtar, MD, Suzanne R. Hayman, MD, Saad S. Kenderian, MD, Jose F. Leis, MD PhD, Yucai Wang, MD PhD, Amie Fonder, PA-C, MS, Min Shi, MD PhD, Daniel L. Van Dyke, PhD, Susan M. Schwager, Susan L. Slager, PhD, Neil E. Kay, MD, Sameer A. Parikh, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3037.
https://doi.org/10.1182/blood-2019-131154
Published: 2019